France Inhaler Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
France inhaler market was valued at around $980 million in 2018 and is anticipated to grow at a substantial rate of 3.6% during the forecast period. As per French government agency, Business France, the country ranked as 4th globally and second in Europe for medical device and technology industry. There are about 1,300 to 1,350 companies in French device manufacturer that generated a revenue of around $32 billion in 2017. The country is generating about $9.5 billion in 2017 by export of medical devices. The medical device market is providing employment to about 85,000 people in the country. This provides a significant base for the growth of medical inhaler market over the forecast period.
To Request a Sample of our Report on France
Inhaler Market: https://www.omrglobal.com/request-sample/france-inhaler-market
The France inhaler market is
segmented on the basis of device, type, application, and end-user. On the basis
of device, the market is sub-segmented into metered dosed inhaler, dry powdered
inhaler, and nebulizer. The dry powder inhaler is estimated to have largest
market share in the France inhaler market due to providing easy inhalation
solution. Whereas, the market for metered dose inhaler is estimated to be the
fastest growing at a CAGR during the forecast period owing to innovations and
collaborations by the companies for the development of metered dosed inhaler.
Based on the type, preventive, reliever, and long acting bronchodilators
inhaler are analyzed. Moreover, on the basis of application, the market has
been classified into asthma and COPD diseases. In addition, based on the
end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of France Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/france-inhaler-market
France Inhaler Market Segmentation
By Device
·
Metered Dose Inhaler
·
Dry Powder Inhaler
·
Nebulizer
By Type
·
Preventive Inhaler
·
Reliever Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
Air Liquide S.A.
·
AstraZeneca PLC
·
Bespak
·
Boehringer Ingelheim International GmbH
·
Chiesi Farmaceutici S.P.A.
·
GlaxoSmithKline PLC
·
H&T Presspart Manufacturing Ltd.
·
Koninklijke Philips N.V.
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Teicos Pharma Ltd.
·
Teva Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment